United Benefit Advisors Insight and Analysis Blog

Self-Funding Dental: Leave No Stone Unturned

Posted by: Gary R. Goodhile, CLU    Mar 30, 2017 9:29:00 AM

With all of the focus that is put into managing and controlling health care costs today, it amazes me how many organizations still look past one of the most effective and least disruptive cost-saving strategies available to employers with 150 or more covered employees – self-funding your dental plan. There is a reason why dental insurers are not quick to suggest making a switch to a self-funded arrangement … it is called profit!

Read More

Topics: self-funding, dental insurance, benefits cost control, health care cost containment

Employers and Employees Teeter on Healthcare Cost and Coverage Tightrope

Posted by: Elizabeth Kay    Nov 21, 2016 12:08:52 PM

Over the past few years, we have seen the cost of health care steadily increase – a trend supported by the latest data from the 2016 UBA Health Plan Survey. During the recession, employers implemented health plans with higher copays, higher deductibles, or offered multiple plans with a variety of deductibles and pushed the cost of the lower deductible plans onto employees in an attempt to keep their costs for offering coverage at the same rate or less.

Read More

Topics: consumer-driven health plan, Elizabeth Kay, UBA Health Plan Survey, health care cost, benefits cost control, group medical benefits

See Which Employers Are Aggressively Increasing Rx Tiers for Cost Savings

Posted by: Bill Olson    Jul 21, 2016 10:30:00 AM

The Latest UBA Survey data shows employers are flocking to two strategies to control rising prescription drug costs: moving to blended copay/coinsurance models vs. copay only, and adding tiers to the prescription drug plans. Almost half (48.9%) of prescription drug plans utilize three tiers (generic, formulary brand, and non-formulary brand), 4.3% retain a two-tier plan, and 44.1% offer four tiers or more. The number of employers offering drug plans with four tiers or more increased 34% from 2014 to 2015. The fourth tier (and additional tiers) pays for biotech drugs, which are the most expensive. By segmenting these drugs into another category with significantly higher copays, employers are able to pass along a little more of the cost of these drugs to employees. Over the last two years, the number of plans with four or more tiers grew 58.1%, making this a rapidly growing strategy to control costs.

Read More

Topics: UBA Health Plan Survey, prescription drug plans, prescription drug cost, benefits cost control, Rx